PATENT ABSTRACT
An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.

PATENT DESCRIPTION
CROSS-REFERENCE TO RELATED APPLICATIONS 
     This application is a continuation of U.S. patent application Ser. No. 13/029,069, filed Feb. 16, 2011, now U.S. Pat. No. 8,517,973, which is a continuation of U.S. patent application Ser. No. 10/826,237, filed Apr. 17, 2004, now U.S. Pat. No. 7,909,790, which is a continuation of U.S. patent application Ser. No. 10/700,863, filed Nov. 3, 2003, now U.S. Pat. No. 7,311,690, which claims the benefit of priority to U.S. Provisional Patent Application No. 60/496,441, filed Aug. 21, 2003 and is a continuation-in-part of U.S. patent application Ser. No. 10/369,550, filed Feb. 21, 2003, now U.S. Pat. No. 7,335,179, which claims the benefit of priority to U.S. Provisional Patent Application No. 60/389,346, filed on Jun. 18, 2002, and to U.S. Provisional Patent Application No. 60/359,287, filed on Feb. 25, 2002, the contents of which are incorporated herein by reference in their entirety. 
    
    
     FIELD OF THE INVENTION 
     The invention is generally in the field of medical devices. More particularly, it relates to implantable pump-assisted drainage devices, e.g., for transvesicluar drainage, capable of draining fluid from a bodily cavity into another bodily cavity, such as a bladder. 
     BACKGROUND OF THE INVENTION 
     There are a variety of conditions which result in pathologic chronic collection of bodily fluids within the body of a person. Chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, chronic pulmonary effusion, pulmonary edema, and ascites are but a few of the conditions in which chronic fluid collections persist and result in increased morbidity and mortality. 
     These types of conditions currently are treated typically by one of three methods: 1) external drainage with a high-risk of infection and long-term requirement for multiple punctures, 2) drainage to another body cavity, or 3) treatment with various drugs. For pericardial effusions and hydrocephalus of all types, the treatment of choice is typically drainage to another region of the body. For pericardial effusions this entails a pericardial window, a highly invasive procedure in which a large section of the external heart cavity is removed. For hydrocephalus, the treatment typically involves the use of a ventriculo-peritoneal shunt draining the cerebrospinal fluid into the peritoneal cavity. This device frequently becomes clogged due to the proteinaceous environment of the peritoneal cavity and requires removal or revision. 
     One problem which may arise with the chronic collection of bodily fluids is ascites, which is a highly debilitating complication associated with many medical conditions including liver failure and congestive heart failure. Untreated ascites can result in respiratory compromise, compression of the inferior vena cava (a vital blood vessel) and spontaneous bacterial peritonitis (a life-threatening condition). In order to treat chronic ascites, medicine has turned to both drugs and surgery. 
     The drugs required to treat ascites are typically long-term and frequently result in complications. The most common pharmaceutical treatment of ascites involves the use of diuretics to remove fluid from the patient&#39;s body through their urine. The difficulty with this treatment, though, is that fluid is removed from the entire body, including the circulating volume of blood, and can result in excessive loss of fluid required to perfuse the vital organs of the human body. Thus, even with frequent application, the medicines frequently fail. In such cases, surgical, or invasive; procedures are indicated. 
     Currently the most common surgical treatment is paracentesis. In paracentesis, the peritoneal fluid is drained through the abdominal wall via the insertion of a needle through the abdominal wall into the peritoneal cavity. This procedure is only a temporary solution as the ascites quickly refills the peritoneal cavity in most chronic conditions. Furthermore, repeated paracenteses places the patient at increased risk for a life-threatening infection of their peritoneal cavity. Other surgical/invasive procedures typically involve treatment of the cause of the ascites (for example, the Transjugular Intrahepatic Portosystemic Shunt) but these measures also frequently result in complications, which are often serious and are thus performed infrequently. 
     Many of the existing commercially available devices provide little improvement over the intermittent punctures of paracentesis and result in increased rates of infection or other complications if left in place for any length of time. Therefore, there is a need for a device which effectively reduces the need for repeated punctures or abdominal incisions and thereby reduces the risk of serious infection. 
     SUMMARY OF THE INVENTION 
     An implantable fluid management system, as described herein, may typically comprise a first tube member having a first end, a second end, and a length which defines a lumen therethrough and having at least one opening at the first end or along the length, a second tube member having a first end, a second end, and a length which defines a lumen therethrough, a pump fluidly coupled to the first tube member and the second tube member for urging fluid through each tube member, and a shunt connected to the second end of the second tube member, wherein the shunt is adapted to anchor the second end of the second tube member to a wall of a hollow body organ in a fluid-tight seal. 
     This system may avoid difficulties typically associated with the current therapies. For instance, in the treatment of chronic ascites, the devices of the system may allow for the removal of peritoneal fluid without 1) serious complications generally associated with use of pharmaceuticals, 2) inconvenience, for example, the substantial costs and the increased risk of infection associated with frequent paracenteses, or 3) multiple severe complications associated with more invasive and risky surgical operations to treat the cause of ascites. The implantable fluid management system may be utilized for chronic excess fluid drainage from one bodily cavity to a second bodily cavity, e.g., a urinary bladder. An implantable electromechanically powered and/or magnetically coupled vesicular pump may be utilized to permit assisted flow of the excess fluid collections into the bladder. This flow may be directed to be uni-directional through the system. 
     One particular variation of the system may be used as an ascites drainage device. For instance, the device of the system may be used for peritoneovesicular drainage of the peritoneal fluid from the peritoneal cavity into, e.g., the bladder. The drainage of the fluid may be uni-directional through the system. To urge the fluid through the fluid management system, a pump which is fully implantable may be utilized with the system to transfer excess fluid from a variety of locations in the human body, for instance, the peritoneal cavity, to another region within the body, for instance, the urinary bladder, for the treatment of chronic fluid collections. 
     The system, including the pump and/or tubular members, may be configured to enable fluid flow in only one direction into, e.g., the bladder, to prevent the reflux of urine or other fluids into the area being drained while still allowing the drainage of the fluid into the bladder. This uni-directional configuration may be achieved through incorporation of a uni-directional valve in the lumen of the tubing or through the use of a uni-directional pump which may also be prevented from being driven in reverse. 
     The device may include at least two distinct flexible tubular members each defining at least one lumen therethrough. One tubular member may be used for drawing fluid from the region to be drained into or through the pump while the other tube may be used for channeling the fluid from the pump into the hollow body organ such as the bladder. The tube for drawing the excess fluid from the body cavity may contain or define at least one opening, and may preferably define multiple perforations, and/or anti-clogging mechanisms in the region of the fluid intake. This tubular member may also optionally incorporate chemical- or pressure-sensing elements to trigger and/or prevent activation of the pump under specific circumstances. The tubular member carrying the pumped fluid to the bladder may feature an anchoring mechanism such as a shunt mentioned above (e.g., a flange, pigtail coil, etc.) and may optionally be coated with a hydrophilic material to prevent encrustation. The tip of this tubing may also optionally incorporate chemical- or pressure-sensing elements to trigger and/or prevent activation of the pump under specific circumstances ensuring that the pump does not generate excessive bladder pressures. These sensors can be placed anywhere along the length of either tube, including the extremes of a position at the site of pump attachment and a position at the tip of the tubing. Optionally, the two tubes can be integrated together into a single tubular member having two distinct lumens for ease of insertion. 
     The shunt for anchoring to the bladder wall may, in one variation, comprise a hollow, cylindrical column with flanges at either or both ends to provide secure anchorage in the bladder wall. The shunt may have an integrated mechanism to ensure uni-directional flow of fluid while preventing reflux of urine and other fluids back through the shunt. One variation of the shunt may provide a passive ball-valve mechanism which allows for drainage of fluid into the bladder whenever a certain minimum threshold pressure is achieved at the collection site. Another variation may provide an active valve mechanism which allows for controlled drainage of fluid into the bladder whenever the valve is actuated. 
     The system can be made available in multiple configurations and designs for varying types and severity of fluid collections. For drainage of excess cerebrospinal fluid, for example, the tubing connecting the pump to the ventricle of the brain may be fabricated to be significantly longer than the tubing for chronic ascites which need only reach an adjacent peritoneal cavity. 
     The methods of insertion of the fluid management system may be based, in part, on the location of the fluid collection. On the other hand, the tubular member spanning to the bladder wall may be placed, e.g., cystoscopically or transabdominally, using minimally invasive procedures. The pump may be placed subcutaneously using interventional radiology techniques including radiographic imaging such as ultrasound. The inflow tubing connected to the pump, in one variation, may be tunneled subcutaneously to the site of drainage and the outflow tubing can be subcutaneously channeled to the bladder. Alternatively, the pump can be placed in the peritoneal cavity, or other bodily cavity, and activated remotely or set to operate independently based on pressure signals sensed from the fluid. In this variation, the pump may be tethered to an inductive charging coil for recharging or, if a battery with sufficient life is used, may carry its own independent power supply. 
     The system may also optionally include controls to limit the operation of the pump and provide feedback to ensure that the pump is operating correctly. Thus the total fluid flow can be monitored and tightly controlled. 
    
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
         FIG. 1  shows a cross-sectional view of a variation of a shunt device. 
         FIG. 2  shows a cross-sectional view of an implanted shunt. 
         FIG. 3  shows a cross-sectional view of the implanted shunt when the peritoneal fluid pressure is insufficient to open the valve. 
         FIG. 4  shows a cross-sectional view in an illustration of an example of an insertion device within which the shunt can be implanted in the bladder wall. 
         FIGS. 5A to 5C  show alternative variations of the fluid management system with differing valve types, differing valve positioning and differing number of valves. 
         FIGS. 6A and 6B  show cross-sectional illustrations of an alternative variation of the system and a detail view of the shunt, respectively, in which an active, externally, or internally controlled valve is utilized. 
         FIG. 7  shows a cross-sectional illustration of an alternative variation of the drainage system in which a pump may be included along the length of the tubing. 
         FIGS. 8A to 8C  show illustrations of a few of the alternative variations of the drainage system in which the peritoneal cavity, the pulmonary space, and the ventricular space are able to be drained. 
         FIG. 9  shows an illustrative magnetically-coupled variation of the drainage system with an illustration of an externally located drive. 
         FIGS. 10A to 10C  show a variation of the drainage system in which the tubes and pump may be removably attachable allowing for increased ease of insertion. 
         FIG. 11A  show, is an implantable pump variation having removably attachable tubing in the attached position. 
         FIG. 11B  shows a variation on an implantable pump which may have its moment forces generated by the pump balanced. 
         FIG. 12A  shows a variation of the drainage system having a single dual-lumen tube. 
         FIGS. 12B to 12G  show additional variations of the single dual-lumen tube. 
         FIG. 13  shows a magnetically-coupled variation of the pump and external drive in which the magnetic interaction is circumferential. 
         FIG. 14  shows an illustration of an electromechanical variation of the system in which the implanted pump may be rechargeable. 
         FIG. 15  shows an illustration of an electromechanical variation of the device in which the implanted pump may be placed in a non-subcutaneous position. 
         FIGS. 16A to 16C  show illustration of a few of the possible uses of the drainage system in the drainage of chronic fluid collections in various regions of the body. 
         FIG. 17  shows a variation of the drainage system which may be fluidly coupled to the vascular system. 
         FIG. 18  shows another variation of the drainage system which may be coupled to a stomach or another portion of the gastro-intestinal system. 
     
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
     The implantable fluid management system may comprise devices for facilitating the removal of fluid from a body region where drainage is desired. For instance, the devices disclosed herein may be utilized for chronic excess fluid drainage from one bodily cavity to a second bodily cavity, e.g., a urinary bladder. An implantable electromechanically powered and/or magnetically coupled vesicular pump may be utilized to permit assisted flow of the excess fluid collections into the bladder. This flow may be directed to be unidirectional through the system. 
     As can be seen in  FIG. 1 , a vesicular shunt or drain  1  may be utilized with the fluid management system for anchoring a tubing member to the wall of a urinary bladder. A further detailed description of the shunt and its applications may be seen in U.S. application Ser. No. 10/369,550 filed on Feb. 21, 2003, which has been incorporated herein by reference above. Shunt or drain  1  may be implanted in the bladder wall  9 , as shown in  FIG. 2 , and can be configured to provide for unidirectional drainage of fluid into the bladder. In one variation, the shunt or drain  1  may comprise a flange or projection  2 ,  3  at each end of the shunt  1  to facilitate firmly anchoring the shunt  1  across the bladder wall  9 . Alternative variations of the shunt  1  may utilize other anchoring mechanisms, including, but not limited to, screw threading on the outside of shunt  1 , staples, sutures, adhesive compounds, one or more barbs, etc., and combinations thereof. 
     In one variation, the shunt  1  may be configured to define a lumen through the shaft of the device with a valving mechanism positioned within this lumen. For instance, a ball-valve  4  may be positioned to obstruct an inflow opening of the lumen. A biasing element such as a spring  5  may be configured to provide a closing pressure against the ball-valve  4  such that the lumen remains shut until a minimum threshold pressure is developed by the fluid which may force the ball-valve  4  open or until a pump is actuated to open the valve  4 . The inflow port of the shunt  1  may optionally include a porous mesh or filter  6  to allow for the free flow of fluid through shunt  1  while preventing the incarceration of tissues at the drainage site. Moreover, the mesh or filter  6  may be configured to filter the fluid through a polymer to sequester components which may be present within the fluid, such as albumin and other proteins, while allowing the flow of fluids and ions across the semi-permeable membrane. 
     As can be seen in the variation of  FIG. 2 , once a pressure of the collected peritoneal fluid  19  has built up, in this case within the peritoneal cavity  7 , and exceeds the combined threshold force of the spring  5  and a pressure of the fluid-filled bladder cavity  8 , the peritoneal fluid  19  may urge the ball-valve  4  open to then allow fluid flow into the bladder  8 . Once the peritoneal fluid  19  has entered the bladder, the peritoneal fluid  19  may mix with the urine  20  and any other fluids which may be present. Once a sufficient amount of fluid  19  has passed through shunt  1  and the fluid pressure within the peritoneal cavity  7  falls below the threshold pressure of the spring  5 , the ball-valve  4  may be urged shut to prevent further fluid flow through the shunt  1 . The spring force exerted by the biasing element to shut the valve  4  within the shunt  1  may be varied depending upon the amount of fluid flow desired. 
     If the combined pressure from the fluid pressure within the bladder  8  and the closing force of the spring  5  is greater than the pressure exerted by the collected fluid within the peritoneal cavity  7 , then the valve  4  will remain closed preventing reflux of urine and other fluids back into the peritoneal cavity  7 , as depicted in  FIG. 3 . 
     The shunt  1  may be designed to be deployed transurethrally or transabdominally via an insertion device  10 , such as that depicted in the variation of  FIG. 4 . Various devices such as endoscopes, catheters, introducers, etc., may also be utilized as an insertion device  10  depending upon the patient anatomy and the location where the shunt  1  is to be placed. A specially configured insertion device  10  may define a cavity or channel within which the shunt  1  may be positioned for deployment within a patient. The variation shown in the figure may incorporate flexible flanges  2 ,  3  on one or both ends of the shunt  1 . During delivery, one or both flanges  2 ,  3  may be configured in a low profile configuration and after delivery, one or both flanges  2 ,  3  may be configured to self-expand or reconfigure into a larger configuration. Accordingly, flanges  2 ,  3  may optionally be fabricated from spring steels, shape memory alloys and superelastic alloys such as nitinol, etc. Once the distal end of insertion device  10  has been brought into proximity or adjacent to the region of tissue where shunt  1  is to be inserted, the shunt  1  may be urged out of insertion device  10  via a pusher or plunger, as shown in the figure. Alternatively, shunt  1  may be positioned upon the distal end of an insertion device and released into the tissue wall via a release mechanism. 
     A tubing member  11  may be attached to the inflow port of shunt  1 . This tubing member  11  may be made such that it is sufficiently long enough to reach the region within the body where excess fluid collects. As shown in the illustrative drawings in  FIGS. 5A to 5C , tubing member  11  may have a perforated receptacle  12 , as described in further detail below, through which the collected fluid may drain into the tubing  11 . Other methods for fluid transport may include, but are not limited to, conduits, catheters, saphenous arteries or vessels, artificial tubular grafts, etc. 
     In addition to the shunt  1  having a ball valve  4  in combination with the tubing member  11 , other variations may utilize one or more valves of a variety of different types. For instance, passively-actuated valves, i.e., valves which are configured to automatically open and close without being actively actuated, such as the ball-valve  4  shown in  FIG. 5A  and flapper valve  13  as shown in  FIG. 5B . The flapper type valve  13  may be positioned within shunt  1  near the outflow port, as shown in  FIG. 5B , or it may also be positioned closer to the inflow port, as shown in  FIG. 5C . An additional optional valve  14  may be incorporated into the tubing member  11  anywhere along the length of tubing  11 . The types of valves disclosed are intended to be illustrative and is not intended to be limiting. Other variations of the valves are intended to be within the scope of this disclosure. 
     Alternatively, active valves, i.e., valves which may be configured to open and close via an actuation or sensing element, may also be utilized with the fluid management system. The use of active valves may be utilized for maintaining a tighter control of fluid drainage. For instance,  FIG. 6A  shows one variation of an active valve  15  positioned within the lumen of shunt  1  in combination with the tubular member  11 .  FIG. 6B  shows a cross-sectional side view of the shunt  1  alone having the active valve  15  positioned within. Active valve  15  may be actuatable via a remotely located controller to open and shut upon receiving a signal. Alternatively, sensors positioned within the shunt  1  or within the tubing  11  may provide a signal to the active valve  15  to open or shut according to the signal. 
     In another variation, an electronic valve may be configured to become triggered via communication across the tissues of the human body through electromagnetic signals such as radio frequency, microwave, or other electromagnetic frequencies. Alternatively, pressure (patient-applied or otherwise) mechanical, magnetic, or other methods of communication may be utilized to signal allowing for drainage only at selected times. The valve of the device can take many shapes and the device can be manufactured from any of a variety of materials provided that they are biocompatible. 
     The fluid management system may also be configured to incorporate a pump  16 , as shown in  FIG. 7 . Pump  16 , when placed subcutaneously, can be actuated to provide an active pumping mechanism with or without the use of passive or active valves, as described in further detail below. Pump  16  may be configured as a unidirectional pump to facilitate fluid transfer in a single direction. This unidirectional pump feature may be utilized in place of the valve or in combination with the valves. 
     The patient may optionally perform maneuvers to help increase the pressure of any fluid which may be contained within the body cavity. For instance, the patient may bear down to increase intra-abdominal pressure to facilitate drainage of the peritoneal cavity. Alternatively, the patient may also wear or apply a girdle designed to increase abdominal pressure or apply a urethral catheter to decrease bladder pressure. 
     The fluid management system may be configured to drain fluid collections from a variety of different regions within the body. For example, while the shunt  1  may be anchored within the bladder wall, the receptacle  12  may be placed, as described above, within the peritoneal cavity as shown in  FIG. 8A . Another example is shown in  FIG. 8B  where the receptacle  17  may be positioned within the pulmonary space for draining pulmonary effusions and  FIG. 8C  shows an example where the receptacle  18  may be positioned within the cerebrospinal region for draining excess cerbrospinal fluid. In another variation, a receptacle may be positioned within the pericardial region for draining pericardial effusions. 
     In yet another variation, the shunt, pump, or tubular devices may incorporate one or several anti-infective agents to inhibit the spread of infection between body cavities. Examples of anti-infective agents which may be utilized may include, e.g., bacteriostatic materials, bacteriocidal materials, one or more antibiotic dispensers, antibiotic eluting materials, entrained radioisotopes, heating elements, bioactive plastics, surfaces which encourage epithelialization, and coatings which prevent bacterial adhesion, and combinations thereof. 
     Additionally, the devices may also incorporate anti-clogging agents. Examples of anti-clogging agents may include, e.g., active ultrasonic components, an inner and outer sleeve which, when actively agitated through coupling to the pump drive or through a flow driven mechanism, disrupts the inner lumen surfaces which encourage epithelialization, enzyme eluting materials, enzyme eluting materials which specifically target the proteinaceous components of ascites, enzyme eluting materials which specifically target the proteinaceous and encrustation promoting components of urine, chemical eluting surfaces, an intermittent plunger mechanism, coatings which prevent adhesion of proteinaceous compounds, and combinations thereof. The anti-infective and/or anti-clogging agents may be infused through the devices via a reservoir contained, for instance, in the pump or in a separate reservoir. Alternatively, the agents may be integrated within or coated upon the surfaces of the various components of the system. 
       FIG. 9  shows an illustrative detail view of another variation of the system of  FIG. 7  above. As shown, fluid may be drawn up and carried away by the uptake tube  107 , which in this case, has been perforated to prevent blockage. Alternate variations may include an uptake screen at the terminus of the uptake tubing member  107 . Although multiple perforations or openings are shown in tubing member  107 , a single opening may also be defined at the terminal end of the tubing  107  or along the length of the tubing  107 . As mentioned above, the uptake tubing  107  may also include, but is not limited to, conduits, catheters, saphenous arteries or vessels, artificial tubular grafts, etc. The tubing  107  may be positioned where the excess fluid typically collects within the cavity. Tubing  107  may simply be left within the cavity or it may be anchored to a tissue wall via any number of methods for fastening the tubing  107 , e.g., sutures, staples, clamps, adhesives, etc. 
     The uptake tubing  107  leads to the pump  101 , which may be used to actively pump or urge the fluid from the uptake tubing  107  and through the outflow tube  108  and into the bladder  110 . In this variation, an optional bladder anchor or shunt  109  may be utilized to secure the distal end or portion of outflow tube  108  and prevent detachment of tubing  108  during bladder contraction. The bladder anchor or shunt  109  may be configured in any one of the variations as described above for the shunt  1 . 
     The pump  101 , can be powered and operated by electromechanical forces or magnetic coupling. The pump  101  may be placed under the skin  111  in either the subcutaneous space  112  or in the musculature of the abdominal wall  113 . The pump  101  may be configured as a peristaltic pump, but may also be a gear-pump, turbine-pump, impeller-pump, radial-flow-pump, centrifugal-pump, piston-pump, or any other suitable pump type. Ideally, the pump  101  design ensures uni-directional operation. Moreover, the pump  101  may be configured to incorporate a pulsatile or oscillating mechanism within the pump  101  to aid in jarring free any materials from collecting or becoming encrusted to thereby prevent the pump  101  or tubing from clogging. However, valves may be configured to ensure unidirectional operation. The pump  101  is preferably enclosed in a housing, shroud or casing  125  made of any suitable biocompatible material. 
     Also enclosed in the pump housing  125 , in this particular variation, is the magnetically-coupled drive. One, two, or more magnets  103  may be provided to operate the pump  101 . A separate control module  116  which is remotely located from the implanted pump  101  may be used to drive external magnets  105  located within the drive unit  102  or magnets  105  may be used to provide an oscillating or alternating electromagnetic field to correspondingly couple through the skin  111  with a magnetic field of the implanted magnets  103  located within the pump  101 . By rotating or oscillating the magnets  105  in the drive unit  102 , the implanted magnets  103  are stimulated or urged to move, thereby transferring their kinetic force to operate the pump  101 . While  FIG. 9  shows a drive unit  102  with a motor and a linkage, any magnetic field capable of causing or urging the pump magnets  103  to rotate could be used to operate the pump. Furthermore, in order to reduce the torque seen by tissues adjacent to the implanted pump, the pump may utilize a gear mechanism whereby the external drive rotates or oscillates two elements in opposite direction thereby canceling any torques generated. Alternatively, the pump  101  could be electromechanically powered through an implanted battery with external activating and/or monitoring without the requirement for magnetic coupling in which case drive unit  102  may be configured to function as a remote switch for activating the pump  101 . One or more sensors may be integrated into the implanted pump  103  for detecting a variety of fluid and/or pump parameters. For instance,  FIG. 9  shows at least one sensor  104  integrated within implanted pump  101 . A corresponding sensor  106  may be built into the interface of the external drive  102 . Both sensors  104  and  106  may be positioned within their respective units such that when the drive  102  is optimally aligned with implanted pump  101 , the sensors  104 ,  106  may indicate to the physician or patient that the pump  101  and drive  102  are optimally engaged and able to efficiently transfer power and/or information. The drive  102  or some other indicator may be used to convey the presence of an optimal engagement to the physician or patient through a variety of methods, for instance, a visual message or indicator signal such as a light or audible signal may be initiated once the sensors  104 ,  106  have been aligned. These sensors  104 ,  106  may also transfer information from the pump  101  to the drive  102 , and/or from the drive  102  to the pump  101 , during operation to monitor fluid pressures and/or fluid flows. Alternatively, additional magnets could also be utilized to anchor the pump  101  to the drive  102  against rotational forces generated during the power transfer operation. 
     The individual implantable components of the system are shown in detail in  FIGS. 10A to 10C . In  FIG. 10A , the outflow tubing  108  is shown in one variation in its insertion trocar  117 . Also illustrated are the bladder anchor  109  and an optional removably attachable port  118  which may be designed to couple with an insertion port  120  on the pump  101 .  FIG. 10B  illustrates one variation of the inflow drainage tubing  107  in an insertion trocar  117  with an optional removably attachable port  119 . Although these variations show the tubing  107 ,  108  positioned within insertion trocars  117  for deployment within a patient, the tubing  107 ,  108  may be implanted through various other methods as may be contemplated by one of ordinary skill in the art. 
       FIG. 10C  illustrates one variation of the implantable pump  101  with tubing detached. The pump  101  is illustrated with anchors  121  to resist rotational forces generated with pump use. The pump housing  125  may be anchored by barbed insertion pins  121  and/or materials designed to promote fibrotic ingrowth for anchoring the pump  101  within the muscle  113  or subcutaneous space  112 . Alternative variations of the pump device  101  may use other anchoring mechanisms, e.g., screw threading defined on outside surfaces of pump  101 , staples, sutures, adhesive compounds, a porous solid promoting interstitial cell growth, one or more pins designed to be inserted into the abdominal wall, etc., and combinations thereof. In the variation shown, the tubing  107 ,  108  and pump  101  are separate components and may placed individually. For instance, the two tubes  107 ,  108  may be first inserted through a single incision in the skin and placed in their approximate positions within the patient. The pump  101  may then be inserted through the incision and attached to both tubes  107 ,  108  and secured at the implantation site. Alternatively, the tubing  107 ,  108  may be attached to the pump  101  prior to implantation or during manufacture and the entire system may be implanted as a single system. 
       FIG. 11A  illustrates the pump  101  and tubing  107 ,  108  of  FIGS. 10A to 10C  in which the tubing  107 ,  108  has been attached to the corresponding outflow and inflow ports of pump  101  at the junctures of tubing port  118  to pump  120  and tubing port  119  to pump  120 . Also shown are optional sensors  122 ,  124  on the ends of the inflow tubing  107  and outflow tubing  108 , respectively. One or both of these sensors  122 ,  124  may be configured to sense any one of a number of fluid parameters. For instance, one or both sensors  122 ,  124  may detect fluid pressures and/or various chemical parameters such as pH of the fluid, or the presence of certain chemicals, etc. One or both sensors  122 ,  124  may also be configured to provide positive and/or negative feedback to the control mechanism, such as the externally located drive unit  102  or an integrated controller located within the pump  101 , in the control of fluid flows. Although both sensors  122 ,  124  are shown located at the terminal ends of tubing  107 ,  108 , respectively, they may optionally be located anywhere along the lengths of their respective tubes  107 ,  108 , if desired or necessary. 
       FIG. 11B  shows a cross-sectional view of another variation of pump  101  which may be utilized to effectively eliminate any excessive movement which may be imparted by torquing forces generated by the pump  101 . After pump  101  has been implanted within a patient, it is generally desirable to inhibit movement of the pump  101  within the body. This may be accomplished through a variety of methods, such as securely anchoring the pump  101  to the surrounding tissue. This pump variation may also be configured to reduce any torque which may be seen by tissues adjacent to the implanted pump  101 . This may be accomplished, in part, by utilizing at least two counter-rotating or counter-oscillating elements within the pump  101  which may rotate or oscillate during pumping such that oppositely generated moments or rotational moments effectively cancel out or balance each other. As seen in this variation, if a driver unit, such as that described above, were activated to rotate element  138  in a first direction, a first rotational moment  141  is generated. This moment  141 , if unbalanced, may impart forces from the pump  101  to the surrounding tissue potentially resulting in damage to the tissue. Element  138  may be rotationally coupled to a gear box  140  which may be configured to reverse the imparted direction of rotation such that element  139 , which is also rotationally coupled to gear box  140 , is compelled to rotate in an opposite direction from element  138  thus creating a rotational moment  142 . The opposite rotational moments  141 ,  142  may effectively balance or cancel one another such that the net force imparted by the pump  101  to the surrounding tissue is minimized, potentially to a zero load. The counter-rotating or counter-oscillating (depending upon the type of pump utilized) elements within a pump may be balanced in mass and in configuration in any number of ways to optimize the resulting effect on the pump, depending upon the desired effects. 
       FIG. 12A  illustrates one variation of the fluid management system in which both inflow  107  and outflow  108  tubing share a common wall. This arrangement may be utilized ideally for the peritoneal fluid draining design because the bladder  110  and peritoneal cavity  115  share a common wall which facilitates the insertion of a single dual-lumen tube. Also shown is flange  123  which can be utilized to prevent insertion of the inflow tubing  107  into the bladder  110  in the case of the single-puncture placement. Moreover, any one of the shunt  1  variations described above may be utilized with this variation. 
       FIGS. 12B and 12C  show cross-sectional side and end views, respectively, of the tubing variation of  FIG. 12A . As shown, inflow tubing  107  and outflow tubing  108  may share common wall  133 , which may be reinforced to maintain the structural integrity of the tubing. The inflow tubing  107  may define one or a plurality of openings  134  for drawing the fluid within tubing  107 . Openings  134  may be defined along just a portion of tubing  107  or it may be defined along a majority of the length of tubing  107  depending upon the desired application. In operation, the fluid within the body cavity may be drawn into tubing  107  through openings  134  and drawn into pump  103 . The fluid may then be passed through outflow tubing  108  in the opposite direction as the fluid flowing through inflow tubing  107  and subsequently into the bladder  110 .  FIGS. 12D and 12E  show another variation of tubing  107 ′ and  108 ′ in which both tubes are formed from a single extrusion  135 . In this variation, tubing  107 ′ may define one or a plurality of openings  134 .  FIGS. 12F and 12G  show cross-sectional side and end views of yet another variation of a single-tube dual-lumen variation in which outflow tubing  108 ″ may be coaxially positioned within inflow tubing  107 ″. In this variation, openings  134  may be defined along a length of inflow tubing  107 ″ while outflow tubing  108 ″ may remain intact. 
     Both inflow and outflow tubing, or just one of the tubes, may be reinforced along a portion of its length of along its entire length. Reinforcement of the tubing may be accomplished via ribbon or wire braiding or lengths of wire or ribbon embedded or integrated within or along the tubing. The braiding or wire may be fabricated from metals such as stainless steels, superelastic metals such as nitinol, or from a variety of suitable polymers. 
       FIG. 13  illustrates one variation of the pump device in which the magnetic coupling mechanism employed allows for circumferential interaction. As shown, the pump  101  may be implanted under the skin  111  yet close to the surface such that the pump magnets  103  may be positioned within the inner diameter of, and/or in the same plane as, the external drive magnets  105 . The arms  127  of the drive unit may protrude to define a circumferential cavity for receiving the implanted pump  101  and the overlying skin  111  within this channel. The design of the holding arms  127  may be blunted to prevent excessive pressure from being exerted upon the skin  111  over the site of insertion. In this variation, the driveshaft  126  is shown which transfers power to the magnet holding arm  127  of the drive. This design can also employ one or several pump anchors  121 , sensors  104 ,  106  and/or other features and combinations of the pump and tubing. 
       FIGS. 14 and 15  illustrate non-magnetically powered pumps in which the implanted pump may be powered by a battery or other implantable power source. In this instance the pump  101  may communicate with the external interface  116  using radiowave or electromagnetic signal generators and receivers  128 ,  129  to transfer information and/or activation signals. This pump  101  can be placed subcutaneously (as shown in  FIG. 14 ) or in any other region suitable for implantation (for instance, the pump  101  of  FIG. 15  may be implanted directly within the peritoneal cavity) so long as it can communicate with the external component  116 . The pump can also be internally controlled using the sensors  122 ,  124  to determine when to activate the pump. These variations may be configured so that the physician or patient may be able to intervene using the external control mechanism  116  in order to prevent the operation of the pump  101  in undesirable circumstances. For example, if the sensors detect negative feedback, the physician and/or patient may activate the pump  101  using the external controls  116  at their discretion. The controls, though, may be easily programmed to incorporate various parameters such as a maximum drainage per day and simple drainage controls such as no drainage when the bladder exceeds a certain pressure. The pump  101  can also be programmed to be activated under certain circumstances, e.g., once the peritoneal pressure sensor  122  experiences a pressure above a certain threshold. 
     The device may be designed to drain a variety of different fluid collections including, but not limited to, the excess fluid within the peritoneal cavity, as shown in  FIG. 16A , pulmonary effusions, as shown in  FIG. 16B , and excessive cerebrospinal fluid, as shown in  FIG. 16C . These figures show the bladder anchor  109 , the outflow tube  108 , the pump  101 , the inflow tube  107 , and the drainage ports for the peritoneal  130 , pleural  131  and cerebrospinal  132  drainage sites, although other variations utilizing different features, such as the single tube, dual-lumen tubing described above may be substituted in further variations. Moreover, drainage from other regions of the body using the system and variations thereof are contemplated, such as application for drainage of pericardial effusions. It is important to note that any feature of the present invention can be incorporated into any these designs. 
     The housing, shroud or casing  125  of the pump can take many shapes and the pump housing  125  can be manufactured from any of a variety of biocompatible materials. Alternatively, the pump housing  125  may incorporate anti-infective components or agents in order to prevent the spread of infection between the body cavities. Such anti-infective components or agents may include, e.g., bacteriostatic materials, bacteriocidal materials, one or more antibiotic dispensers, antibiotic eluting materials, entrained radioisotopes, heating elements, bioactive plastics, surfaces which encourage epithelialization, coatings which prevent bacterial adhesion, etc., and combinations thereof. Alternatively, the device may also incorporate anti-clogging components, e.g., active ultrasonic components, surfaces which encourage epithelialization, enzyme eluting materials, chemical eluting surfaces, coatings which prevent adhesion of proteinaceous compounds, etc., and combinations thereof. 
     The device has been designed to allow for minimally invasive placement, ideally through the use of non-invasive radiographic imaging tools such as abdominal ultrasound. Placement of the fluid management system may be facilitated by filling the bladder  110  and using ultrasound to locate this space; the outflow tubing  108  can then be placed through a small incision and a simple puncture. The inflow tubing  107  can also be placed in a similar manner using subcutaneous tunneling of the tubing and ultrasound guidance. Once the tubing has been placed, the outflow tubing  107  and the inflow tubing  108  may then be attached to the pump  101  at the insertion sites. The pump  101  may then be set into its site of implantation (for instance, in the subcutaneous space) after which the wound is closed and allowed to heal. 
     Another application for the fluid management system may be seen in  FIG. 17 , which shows outlow tubing  108  fluidly coupled in a fluid-tight seal to the vasculature  136  of the patient. The fluid collected through inflow tubing  107  may be urged via pump  101  through outflow tubing  108  and passed into the vasculature  136  via an anastomotic connection at one of any number of suitable locations along the vasculature. In such a variation, the outflow tubing  108  may be a saphenous vein or artery. The anastomotic connection between tubing  108  and the vasculature is preferably a fluid-tight seal and may be accomplished through any variety of methods as known to one of skill in the art. 
     Yet another variation is shown in  FIG. 18 , which shows outflow tubing  108  fluidly connected to a stomach  137  of the patient. The collected fluid may be passed into the stomach  137  through use of the shunt described above or through another anastomotic connection to allow for the absorption of any additional nutrients which may be present in the excess fluid. The fluid urged into the stomach may then be passed through the gastro-intestinal system of the patient and eventually voided from the body. Although this example shows fluid connection to the stomach  137 , outflow tubing  108  may alternatively be coupled to other suitable regions of the gastro-intestinal tract, such as regions of the small and large intestinal tracts. 
     While the device is primarily contemplated for use in human patients, the invention will also have veterinary uses or product development purposes in equine, bovine, canine, feline, and other mammalian species. 
     The applications of the devices and systems discussed above are not limited to certain treatments, but may include any number of other maladies. Modification of the above-described methods for carrying out the invention, and variations of the mechanical aspects of the invention that are obvious to those of skill in the arts are intended to be within the scope of the claims. Moreover, various combinations of aspects between examples is also contemplated and is considered to be within the scope of this disclosure.